Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis

  • Irene Rodríguez-Hernández1, 2, 3,
  • Marta Vázquez-Cedeira1, 2,
  • Angel Santos-Briz3, 4,
  • Juan L García1,
  • Isabel F Fernández1, 3,
  • Juan A Gómez-Moreta5,
  • Javier Martin-Vallejo6,
  • Rogelio González-Sarmiento1, 2, 3Email author and
  • Pedro A Lazo1, 2Email author
Contributed equally
BMC Clinical Pathology201313:23

DOI: 10.1186/1472-6890-13-23

Received: 10 May 2013

Accepted: 27 September 2013

Published: 1 October 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
10 May 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 May 2013 Author responded Author comments - Pedro A. Lazo
Resubmission - Version 3
20 May 2013 Submitted Manuscript version 3
29 Jun 2013 Reviewed Reviewer Report - Keiichi Sakai
8 Jul 2013 Reviewed Reviewer Report - Uttara Chatterjee
26 Aug 2013 Author responded Author comments - Pedro A. Lazo
Resubmission - Version 4
26 Aug 2013 Submitted Manuscript version 4
Publishing
27 Sep 2013 Editorially accepted
1 Oct 2013 Article published 10.1186/1472-6890-13-23

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno
(2)
Instituto de Investigación Biomédica de Salamanca-IBSAL, Hospital Universitario de Salamanca
(3)
Unidad de Medicina Molecular, Departamento de Medicina, Universidad de Salamanca
(4)
Departamento de Patología, Hospital Universitario de Salamanca
(5)
Departamento de Neurocirugía, Hospital Universitario de Salamanca
(6)
Departamento de Estadística, Universidad de Salamanca

Advertisement